The APOBEC-2 crystal structure and functional implications for the deaminase AID

被引:170
作者
Prochnow, Courtney [1 ]
Bransteitter, Ronda [1 ]
Klein, Michael G. [1 ]
Goodman, Myron F. [1 ]
Chen, Xiaojiang S. [1 ]
机构
[1] Univ So Calif, Los Angeles, CA 90089 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature05492
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
APOBEC-2 (APO2) belongs to the family of apolipoprotein B messenger RNA-editing enzyme catalytic ( APOBEC) polypeptides, which deaminates mRNA and single-stranded DNA(1,2). Different APOBEC members use the same deamination activity to achieve diverse human biological functions. Deamination by an APOBEC protein called activation-induced cytidine deaminase ( AID) is critical for generating high-affinity antibodies(3), and deamination by APOBEC-3 proteins can inhibit retrotransposons and the replication of retroviruses such as human immunodeficiency virus and hepatitis B virus(4-7). Here we report the crystal structure of APO2. APO2 forms a rod-shaped tetramer that differs markedly from the square-shaped tetramer of the free nucleotide cytidine deaminase, with which APOBEC proteins share considerable sequence homology. In APO2, two long alpha-helices of a monomer structure prevent the formation of a square-shaped tetramer and facilitate formation of the rod-shaped tetramer via head-to-head interactions of two APO2 dimers. Extensive sequence homology among APOBEC family members allows us to test APO2 structure-based predictions using AID. We show that AID deamination activity is impaired by mutations predicted to interfere with oligomerization and substrate access. The structure suggests how mutations in patients with hyper-IgM-2 syndrome inactivate AID, resulting in defective antibody maturation.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 28 条
[1]   ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing [J].
Anant, S ;
Mukhopadhyay, D ;
Sankaranand, V ;
Kennedy, S ;
Henderson, JO ;
Davidson, NO .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 281 (06) :C1904-C1916
[2]   CYTIDINE DEAMINASE - THE 2-CENTER-DOT-3-ANGSTROM CRYSTAL-STRUCTURE OF AN ENZYME - TRANSITION-STATE ANALOG COMPLEX [J].
BETTS, L ;
XIANG, SB ;
SHORT, SA ;
WOLFENDEN, R ;
CARTER, CW .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (02) :635-656
[3]   Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication [J].
Bonvin, Marianne ;
Achermann, Francois ;
Greeve, Isabell ;
Stroka, Deborah ;
Keogh, Adrian ;
Inderbitzin, Daniel ;
Candinas, Daniel ;
Sommer, Peter ;
Wain-Hobson, Simon ;
Vartanian, Jean-Pierre ;
Greeve, Jobst .
HEPATOLOGY, 2006, 43 (06) :1364-1374
[4]   Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase [J].
Bransteitter, R ;
Pham, P ;
Scharff, MD ;
Goodman, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4102-4107
[5]   First AID (activation-induced cytidine deaminase) is needed to produce high affinity isotype-switched antibodies [J].
Bransteitter, Ronda ;
Sneeden, Jessica L. ;
Allen, Sariah ;
Pham, Phuong ;
Goodman, Myron F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (25) :16833-16836
[6]   Multifaceted antiviral actions of APOBEC3 cytidine deaminases [J].
Chiu, Ya-Lin ;
Greene, Warner C. .
TRENDS IN IMMUNOLOGY, 2006, 27 (06) :291-297
[7]   Structure of human cytidine deaminase bound to a potent inhibitor [J].
Chung, SJ ;
Fromme, JC ;
Verdine, GL .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) :658-660
[8]   Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases [J].
Conticello, SG ;
Thomas, CJF ;
Petersen-Mahrt, SK ;
Neuberger, MS .
MOLECULAR BIOLOGY AND EVOLUTION, 2005, 22 (02) :367-377
[9]   Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors [J].
Cullen, BR .
JOURNAL OF VIROLOGY, 2006, 80 (03) :1067-1076
[10]   Hyper-IgM syndromes [J].
Durandy, Anne ;
Peron, Sophie ;
Fischer, Alain .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) :369-376